Transcription of Case study 29: Warfarin therapy - IMPACT Team
{{id}} {{{paragraph}}}
Example: biology
Case study 29: Warfarin therapy - IMPACT Team
case study 29: Warfarin therapyDecember 2003 An Independent, Australian organisation for Quality Use of MedicinesNational Prescribing Service Limited ACN 082 034 393 Level 7/418A Elizabeth Street Surry Hills NSW 2010 Phone: 02 8217 8700 l Fax: 02 9211 7578 l email: l web: 2 Inside case study 29: Warfarin therapy Scenario and questions page 3 Summary of results page 4 Results in detail page 6 Commentaries Dr Denise Ruth page 12 Dr Sepehr Shakib page 14 References page 16 The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence.
2 Inside Case study 29: Warfarin therapy Scenario and questions page 3 Summary of results page 4 Results in detail page 6 Commentaries Dr Denise Ruth page 12
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Recommended Therapeutic Range for Warfarin, Recommended Therapeutic Range, Warfarin, Therapeutic, Warfarin and its interactions with foods, herbs, Managing Anticoagulant and Antiplatelet Drugs, Vitamin K to Augment Anticoagulation, COUMADIN, Anticoagulation in patients with heart valve, Anticoagulation in patients with heart valve replacements